New patent for Janssen Pharms drug XARELTO

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for XARELTO
Annual Drug Patent Expirations for XARELTO

Xarelto is a drug marketed by Janssen Pharms and is included in two NDAs. It is available from four suppliers. There are five patents protecting this drug and two Paragraph IV challenges.

XARELTO drug price trends.

Drug patent litigation for XARELTO.

This drug has seventy-eight patent family members in forty-six countries.

The generic ingredient in XARELTO is rivaroxaban. Four suppliers are listed for this compound. Additional details are available on the rivaroxaban profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top